International Journal of Breast Cancer · 2013 · 56 citations · 19 references
MedicineOncologyPathologyBreast OncologyMolecular OncologyNeoplasiaAngiogenesisAngiogenesis In CancerBreast PathologyMammary TumorsMolecular Tumor ProfilingAngiogenic Factor ExpressionBenign Breast NeoplasmsBenign Breast TumorsImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingVascular Endothelial Growth Factor
VEGF-A is the most potent angiogenic factor in tumour angiogenesis. Its effects are mediated via two receptors VEGFR-1 and VEGFR-2. Primary aim of our study was to examine the expression of VEGFR-1 in breast cancer and its correlation to VEGF expression, lymph node status, tumour size, histological grade, and hormone receptor status. To examine the VEGFR-1 and VEGF expressions in tumour and surrounding tissue of 51 breast cancer patients, and in healthy breast tissue of 30 benign breast diseases patients, we used three-step immunohistochemical staining. VEGFR-1 and VEGF expressions were significantly increased in breast cancer tumour in relation to surrounding tissue (P < 0.01), and the VEGF expression was significantly increased in lymph node positive breast cancer patients (P < 0.01). VEGFR-1 and VEGF expressions were significantly higher in breast cancer tumour compared with healthy breast tissue (P < 0.01). Significant correlation between VEGF and VEGFR-1 expressions was found (P < 0.05). No significant correlations between VEGF and VEGFR-1 expressions and tumour size, histological grade, and hormone receptor status were found. Increased expression of VEGFR-1 and VEGF in breast cancer tumour and significant correlation between these proteins suggest the possible role of VEGF/VEGFR-1 signalization in breast cancer development, although VEGFR-1 potential prognostic value was not confirmed.
19
World Health Organization Classification of Tumours
CDM Fletcher, Anke van den Berg, Ineke Molenaar · 2002 · 7.1K citations
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Rosandra N. Kaplan, Rebecca D. Riba, Stergios Zacharoulis et al. · Nature · 2005 · 3.2K citations · Full text
Medicine, Cell Biology, Hematology +14
Jennet Harvey, Gary M. Clark, C. Kent Osborne et al. · Journal of Clinical Oncology · 1999 · 2.1K citations
Medicine, Endocrinology, Oncology +17